SET2,3 index can be prognostic in HR+ breast cancer, independent of recurrence score
In an analysis of data from postmenopausal patients with hormone receptor-positive breast cancer, a standard measure of gene expression known as the sensitivity-to-endocrine-therapy (SET2,3) index was found to have prognostic ...